Rating History for Rigel Pharmaceuticals (RIGL) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/9/2020 | Tessa Romero | Downgrade | Neutral (Overweight) |
N/A (N/A) |
2.74 (45.79) |
1571.17% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/9/2020 | Tessa Romero | Downgrade | Neutral (Overweight) |
N/A (N/A) |
2.74 (45.79) |
1571.17% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||